Varinder Jeet
Cited by
Cited by
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
SL Jongbloed, AJ Kassianos, KJ McDonald, GJ Clark, X Ju, CE Angel, ...
Journal of Experimental Medicine 207 (6), 1247-1260, 2010
Modeling prostate cancer: a perspective on transgenic mouse models
V Jeet, PJ Russell, A Khatri
Cancer and Metastasis Reviews 29 (1), 123-142, 2010
MicroRNA theranostics in prostate cancer precision medicine
F Matin, V Jeet, JA Clements, GM Yousef, J Batra
Clinical chemistry 62 (10), 1318-1333, 2016
Differential uptake and cross‐presentation of soluble and necrotic cell antigen by human DC subsets
MC Chiang, KM Tullett, YS Lee, A Idris, Y Ding, KJ McDonald, ...
European journal of immunology 46 (2), 329-339, 2016
A plasma biomarker panel of four microRNAs for the diagnosis of prostate cancer
F Matin, V Jeet, L Moya, LA Selth, S Chambers, JA Clements, J Batra
Scientific reports 8 (1), 1-15, 2018
Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
V Jeet, G Tevz, M Lehman, B Hollier, C Nelson
Endocrine-related cancer 21 (5), 723-737, 2014
Emergence of MicroRNAs as key players in cancer cell metabolism
S Subramaniam, V Jeet, JA Clements, JH Gunter, J Batra
Clinical chemistry 65 (9), 1090-1101, 2019
MicroRNAs in HPV associated cancers: small players with big consequences
S Satapathy, J Batra, V Jeet, EW Thompson, C Punyadeera
Expert review of molecular diagnostics 17 (7), 711-722, 2017
Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer
V Jeet, K Ow, E Doherty, B Curley, PJ Russell, A Khatri
The Prostate 68 (5), 548-562, 2008
Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer
G Tevz, S McGrath, R Demeter, V Magrini, V Jeet, A Rockstroh, ...
Molecular and cellular endocrinology 420, 159-168, 2016
Targeting aurora kinases: a novel approach to curb the growth & chemoresistance of androgen refractory prostate cancer
V Jeet, P J Russell, N D Verma, A Khatri
Current cancer drug targets 12 (2), 144-163, 2012
MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members including prostate-specific antigen in prostate cancer
F Matin, V Jeet, S Srinivasan, AS Cristino, J Panchadsaram, JA Clements, ...
Clinical chemistry 65 (6), 771-780, 2019
Interleukin (IL)-22 from IL-20 subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1/2 pathway
M Moniruzzaman, R Wang, V Jeet, MA McGuckin, SZ Hasnain
International journal of molecular sciences 20 (14), 3468, 2019
Comprehensive profiling of androgen signalling and energy and lipid metabolism highlights heterogeneity of prostate cancer cell lines
MC Sadowski, SJ Mcpherson, A Rockstroh, C Soekmadji, G Tevz, ...
BJU International 118 (S1), 34-34, 2016
Impeding the adaptive response of prostate cancer to androgen targeted therapies with relaxin receptor antagonist
G Tevz, A Hossain, N Bock, V Jeet, RA Bathgate, ED Williams, M Lehman, ...
Bju International 116 (Supplement 1), 36-36, 2015
A biomarker and a therapeutic target: investigating the role of glypican-1 in prostate cancer
V Jeet, A Rockstroh, MC Yeh, DH Campbell, BJ Walsh, PJ Russell, ...
BJU International 122 (S2), 36-37, 2018
Targeted beta therapy of human prostate cancer in vivo with Lu-177 labelled MIL-38 antibody against glypican-1 (GPC-1)
MC Yeh, BWC Tse, NL Fletcher, ZH Huston, C Stewart, K Sokolowski, ...
Bju International 122, 34-35, 2018
Allele specific regulation of PDK1 by miRNAs in prostate cancer
S Subramaniam, V Jeet, C Walpole, CC Nelson, JH Gunter, JA Clements, ...
BJU International 122 (S2), 36-36, 2018
PDK1 dependent aerobic glycolysis and tumorigenesis in prostate cancer is regulated by miRNAs in an allele dependent manner
S Subramaniam, V Jeet, C Walpole, CC Nelson, JH Gunter, JA Clements, ...
BJU International 120 (S1), 19-19, 2017
More than a biomarker: exploring the role of glypican-1 as a new therapeutic target for prostate cancer.
V Jeet, MC Yeh, DH Campbell, BJ Walsh, PJ Russell, CC Nelson
British Journal Of Urology International, 2016
The system can't perform the operation now. Try again later.
Articles 1–20